Mark W Clemens1,2, Garry S Brody1,2, Raman C Mahabir1,2, Roberto N Miranda1,2. 1. Houston, Texas; Los Angeles, Calif.; and Scottsdale, Ariz. 2. From the Departments of Plastic Surgery and Hematopathology, M. D. Anderson Cancer Center; the Department of Plastic Surgery, Keck School of Medicine, University of Southern California; and the Department of Plastic Surgery, Mayo Clinic.
Abstract
LEARNING OBJECTIVES: After reading this article, the participant should be able to: 1. Describe the diagnostic criteria for breast implant-associated (BIA) anaplastic large cell lymphoma (ALCL). 2. Appropriately evaluate a patient with suspected BIA-ALCL, including appropriate imaging, laboratory tests, and pathologic evaluation. 3. Understand the operative treatment of BIA-ALCL, and indications for systemic chemotherapy and/or radiation therapy in advanced disease. 4. Understand treatment outcomes and prognosis based on stage of disease. SUMMARY: The goal of this continuing medical education module is to present the assessment of a patient with suspected breast implant-associated anaplastic large cell lymphoma, the evaluation and diagnosis, the preoperative oncologic workup, the formation and execution of a surgical treatment plan, and the inclusion of adjunct treatments when indicated. In addition, staging and disease progression for treatment of breast implant-associated anaplastic large cell lymphoma are discussed.
LEARNING OBJECTIVES: After reading this article, the participant should be able to: 1. Describe the diagnostic criteria for breast implant-associated (BIA) anaplastic large cell lymphoma (ALCL). 2. Appropriately evaluate a patient with suspected BIA-ALCL, including appropriate imaging, laboratory tests, and pathologic evaluation. 3. Understand the operative treatment of BIA-ALCL, and indications for systemic chemotherapy and/or radiation therapy in advanced disease. 4. Understand treatment outcomes and prognosis based on stage of disease. SUMMARY: The goal of this continuing medical education module is to present the assessment of a patient with suspected breast implant-associated anaplastic large cell lymphoma, the evaluation and diagnosis, the preoperative oncologic workup, the formation and execution of a surgical treatment plan, and the inclusion of adjunct treatments when indicated. In addition, staging and disease progression for treatment of breast implant-associated anaplastic large cell lymphoma are discussed.
Authors: Christopher S Parham; Summer E Hanson; Charles E Butler; M Bradley Calobrace; Raylene Hollrah; Terri Macgregor; Mark W Clemens Journal: Gland Surg Date: 2021-01
Authors: Christopher Conlon; Lauren Pupa; Edward M Reece; Carrie K Chu; Jessie Z Yu; Joshua Vorstenbosch; Sebastian Winocour Journal: Semin Plast Surg Date: 2021-07-06 Impact factor: 2.195
Authors: Alexandra Grubnik; Yastira Ramdas; Barend Van der Bergh; Simon Nayler; Carol-Ann Benn; Bernardo L Rapoport Journal: Case Rep Oncol Med Date: 2022-05-31
Authors: Julian Kricheldorff; Eva Maria Fallenberg; Christine Solbach; Claudia Gerber-Schäfer; Christoph Rancsó; Uwe von Fritschen Journal: Dtsch Arztebl Int Date: 2018-09-21 Impact factor: 5.594